99mTc-B107

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug Name99mTc-B107

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Technetium > 99mTc

Mechanisms of ActionAnti-CD276SPECT contrast agent

TargetsCD276 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSmartnuclide Biopharma

China Registration ClassN/A

Develop Information

Active CompaniesSmartnuclide Biopharma

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A